PortfoliosLab logoPortfoliosLab logo
ARCC vs. LLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ARCC vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ares Capital Corporation (ARCC) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARCC achieves a -2.20% return, which is significantly lower than LLY's 5.78% return. Over the past 10 years, ARCC has underperformed LLY with an annualized return of 13.20%, while LLY has yielded a comparatively higher 33.45% annualized return.


ARCC

1D
1.00%
1M
1.69%
YTD
-2.20%
6M
-2.87%
1Y
-3.87%
3Y*
10.27%
5Y*
9.04%
10Y*
13.20%

LLY

1D
-2.41%
1M
12.74%
YTD
5.78%
6M
10.64%
1Y
39.26%
3Y*
37.45%
5Y*
39.59%
10Y*
33.45%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARCC vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ARCC
Ares Capital Corporation
-2.20%1.07%19.78%20.03%-3.84%36.14%0.86%31.30%8.81%4.50%
LLY
Eli Lilly and Company
5.78%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%

Correlation

The correlation between ARCC and LLY is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.02

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Oct 6, 2004

0.24

The correlation between ARCC and LLY shifts across timeframes, from -0.02 (1 year) to 0.24 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ARCC:

$13.83B

LLY:

$1.02T

EPS

ARCC:

$1.63

LLY:

$28.14

PE Ratio

ARCC:

11.81

LLY:

40.26

PEG Ratio

ARCC:

1.77

LLY:

0.81

PS Ratio

ARCC:

5.16

LLY:

14.08

PB Ratio

ARCC:

0.98

LLY:

32.54

Total Revenue (TTM)

ARCC:

$2.63B

LLY:

$72.25B

Gross Profit (TTM)

ARCC:

$1.86B

LLY:

$59.75B

EBITDA (TTM)

ARCC:

$2.05B

LLY:

$32.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARCC vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARCC
ARCC Risk / Return Rank: 3131
Overall Rank
ARCC Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
ARCC Sortino Ratio Rank: 2626
Sortino Ratio Rank
ARCC Omega Ratio Rank: 2626
Omega Ratio Rank
ARCC Calmar Ratio Rank: 3535
Calmar Ratio Rank
ARCC Martin Ratio Rank: 3535
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 7373
Overall Rank
LLY Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 7070
Sortino Ratio Rank
LLY Omega Ratio Rank: 7171
Omega Ratio Rank
LLY Calmar Ratio Rank: 7474
Calmar Ratio Rank
LLY Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARCC vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ares Capital Corporation (ARCC) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ARCCLLYDifference
Sharpe ratioReturn per unit of total volatility

-1.35

Sortino ratioReturn per unit of downside risk

-1.88

Omega ratioGain probability vs. loss probability

0.97

1.22

-0.25

Calmar ratioReturn relative to maximum drawdown

-0.26

1.72

-1.98

Martin ratioReturn relative to average drawdown

-0.47

4.28

-4.76

ARCC vs. LLY - Sharpe Ratio Comparison

The current ARCC Sharpe Ratio is -0.27, which is lower than the LLY Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of ARCC and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ARCC vs. LLY - Drawdown Comparison

The maximum ARCC drawdown since its inception was -79.36%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for ARCC and LLY.


Loading charts...

Drawdown Indicators


ARCCLLYDifference

Max Drawdown

Largest peak-to-trough decline

-79.36%

-68.24%

-11.12%

Max Drawdown (1Y)

Largest decline over 1 year

-19.35%

-23.64%

+4.29%

Max Drawdown (3Y)

Largest decline over 3 years

-19.35%

-34.48%

+15.13%

Max Drawdown (5Y)

Largest decline over 5 years

-21.76%

-34.48%

+12.72%

Max Drawdown (10Y)

Largest decline over 10 years

-56.77%

-34.48%

-22.29%

Current Drawdown

Current decline from peak

-10.98%

-2.41%

-8.57%

Average Drawdown

Average peak-to-trough decline

-9.10%

-19.21%

+10.11%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.68%

9.49%

+1.19%

Volatility

ARCC vs. LLY - Volatility Comparison

The current volatility for Ares Capital Corporation (ARCC) is 3.72%, while Eli Lilly and Company (LLY) has a volatility of 9.27%. This indicates that ARCC experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ARCCLLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.72%

9.27%

-5.55%

Volatility (6M)

Calculated over the trailing 6-month period

14.83%

27.16%

-12.33%

Volatility (1Y)

Calculated over the trailing 1-year period

18.48%

38.01%

-19.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.96%

32.46%

-12.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.58%

30.19%

-4.61%

Dividends

ARCC vs. LLY - Dividend Comparison

ARCC's dividend yield for the trailing twelve months is around 9.97%, more than LLY's 0.57% yield.


PositionTTM20252024202320222021202020192018201720162015
ARCC
Ares Capital Corporation
7.48%9.49%8.77%9.59%10.12%7.65%9.47%9.01%9.88%9.67%9.22%11.02%
LLY
Eli Lilly and Company
0.57%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%

Financials

ARCC vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Ares Capital Corporation and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
763.00M
19.80B
(ARCC) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

ARCC vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Ares Capital Corporation and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

55.0%60.0%65.0%70.0%75.0%80.0%85.0%90.0%20222023202420252026
72.1%
79.0%
Portfolio components
ARCC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ares Capital Corporation reported a gross profit of 550.00M and revenue of 763.00M. Therefore, the gross margin over that period was 72.1%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

ARCC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ares Capital Corporation reported an operating income of 404.00M and revenue of 763.00M, resulting in an operating margin of 53.0%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

ARCC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ares Capital Corporation reported a net income of 92.00M and revenue of 763.00M, resulting in a net margin of 12.1%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.


Frequently Asked Questions


ARCC and LLY have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LLY has higher volatility (9.27%) compared to ARCC (3.72%). In terms of maximum drawdown, ARCC dropped -79.36% vs LLY's -68.24%.

LLY currently has the higher Sharpe Ratio (1.07 vs -0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ARCC and LLY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer